SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 473.37 |
| Enterprise Value ($M) | 395.32 |
| Book Value ($M) | 422.45 |
| Book Value / Share | 11.93 |
| Price / Book | 1.12 |
| NCAV ($M) | 333.19 |
| NCAV / Share | 9.41 |
| Price / NCAV | 1.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.11 |
| Return on Assets (ROA) | 0.12 |
| Return on Equity (ROE) | 0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.59 |
| Current Ratio | 6.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 465.33 |
| Assets | 554.59 |
| Liabilities | 132.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 8.20 | 1.33 | |
| 13D/A | Baker Bros. Advisors Lp | 13.20 | 3.43 | |
| 13G/A | Roche Finance Ltd | 8.20 | -2.47 | |
| 13G/A | Redmile Group, LLC | 3.80 | -30.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,423 | 161,689 | 18.20 | |
| 18,879 | 109,402 | 17.26 | |
| 24,459 | 164,784 | 14.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TKNO – Alpha Teknova, Inc. | TLPH – Talphera, Inc. |
| TNGX – Tango Therapeutics, Inc. | TRVI – Trevi Therapeutics, Inc. |
| TSBX – Turnstone Biologics Corp. |
Financial data and stock pages provided by
Fintel.io